SIMILAR PATTERNS OF AMINO ACIDS FOR 1IG3_B_VIBB501_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1apa | POKEWEED ANTIVIRALPROTEIN (Phytolaccaamericana) |
PF00161(RIP) | 4 | ASP A 252LEU A 231SER A 211ASN A 207 | None | 1.16A | 1ig3A-1apaA:undetectable1ig3B-1apaA:undetectable | 1ig3A-1apaA:20.961ig3B-1apaA:20.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1c0a | ASPARTYL TRNASYNTHETASE (Escherichiacoli) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon)PF02938(GAD) | 4 | GLN A 333ASP A 416LEU A 321SER A 328 | None | 1.23A | 1ig3A-1c0aA:undetectable1ig3B-1c0aA:undetectable | 1ig3A-1c0aA:18.941ig3B-1c0aA:18.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fng | PROTEIN (MHC CLASSII I-EK, BETA CHAIN) (Mus musculus) |
PF00969(MHC_II_beta)PF07654(C1-set) | 4 | GLN B 156ASP B 121LEU B 180SER B 118 | None | 1.19A | 1ig3A-1fngB:undetectable1ig3B-1fngB:undetectable | 1ig3A-1fngB:22.971ig3B-1fngB:22.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ig0 | THIAMINPYROPHOSPHOKINASE (Saccharomycescerevisiae) |
PF04263(TPK_catalytic)PF04265(TPK_B1_binding) | 4 | TRP A 270SER A 285SER A 287ASN A 288 | None | 0.19A | 1ig3A-1ig0A:25.71ig3B-1ig0A:26.0 | 1ig3A-1ig0A:31.361ig3B-1ig0A:31.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ivl | IGG-KAPPA M29B FV(LIGHT CHAIN) (Mus musculus) |
PF07686(V-set) | 4 | ASP A 82SER A 18SER A 74ASN A 76 | None | 1.11A | 1ig3A-1ivlA:undetectable1ig3B-1ivlA:undetectable | 1ig3A-1ivlA:16.601ig3B-1ivlA:16.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1nfd | N15 ALPHA-BETAT-CELL RECEPTOR (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | TRP B 98SER B 95SER B 30ASN B 31 | None | 1.00A | 1ig3A-1nfdB:undetectable1ig3B-1nfdB:undetectable | 1ig3A-1nfdB:20.291ig3B-1nfdB:20.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ofe | FERREDOXIN-DEPENDENTGLUTAMATE SYNTHASE 2 (Synechocystissp. PCC 6803) |
PF00310(GATase_2)PF01493(GXGXG)PF01645(Glu_synthase)PF04898(Glu_syn_central) | 4 | GLN A1017ASP A1331LEU A 331SER A 366 | None | 1.25A | 1ig3A-1ofeA:undetectable1ig3B-1ofeA:0.3 | 1ig3A-1ofeA:10.881ig3B-1ofeA:10.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1sb3 | 4-HYDROXYBENZOYL-COAREDUCTASE BETASUBUNIT (Thaueraaromatica) |
PF00941(FAD_binding_5)PF03450(CO_deh_flav_C) | 4 | LEU B 309SER B 259SER B 261ASN B 260 | None | 1.25A | 1ig3A-1sb3B:undetectable1ig3B-1sb3B:undetectable | 1ig3A-1sb3B:23.561ig3B-1sb3B:23.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1t5c | CENTROMERIC PROTEINE (Homo sapiens) |
PF00225(Kinesin) | 4 | GLN A 115ASP A 112LEU A 211SER A 175 | None | 1.08A | 1ig3A-1t5cA:undetectable1ig3B-1t5cA:undetectable | 1ig3A-1t5cA:19.781ig3B-1t5cA:19.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1tnd | TRANSDUCIN (Bos taurus) |
PF00503(G-alpha) | 4 | GLN A 168ASP A 169LEU A 155SER A 147 | NoneNoneNoneGSP A 351 (-3.3A) | 0.94A | 1ig3A-1tndA:2.81ig3B-1tndA:2.9 | 1ig3A-1tndA:20.241ig3B-1tndA:20.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1uar | RHODANESE (Thermusthermophilus) |
PF00581(Rhodanese) | 4 | GLN A 116ASP A 212LEU A 9ASN A 90 | None | 1.19A | 1ig3A-1uarA:undetectable1ig3B-1uarA:undetectable | 1ig3A-1uarA:23.051ig3B-1uarA:23.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vm7 | RIBOKINASE (Thermotogamaritima) |
PF00294(PfkB) | 4 | GLN A 135ASP A 246SER A 11ASN A 12 | None | 1.02A | 1ig3A-1vm7A:2.81ig3B-1vm7A:3.8 | 1ig3A-1vm7A:24.361ig3B-1vm7A:24.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2a5h | L-LYSINE2,3-AMINOMUTASE (Clostridiumsubterminale) |
PF04055(Radical_SAM)PF12544(LAM_C) | 4 | GLN A 23ASP A 19TRP A 22SER A 13 | None | 1.25A | 1ig3A-2a5hA:undetectable1ig3B-2a5hA:undetectable | 1ig3A-2a5hA:21.391ig3B-2a5hA:21.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2buk | COAT PROTEIN (unidentifiedtobacconecrosis virus) |
PF03898(TNV_CP) | 4 | LEU A 47SER A 186SER A 34ASN A 33 | None | 1.13A | 1ig3A-2bukA:3.01ig3B-2bukA:3.4 | 1ig3A-2bukA:22.881ig3B-2bukA:22.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2chr | CHLOROMUCONATECYCLOISOMERASE (Cupriavidusnecator) |
PF02746(MR_MLE_N)PF13378(MR_MLE_C) | 4 | GLN A 197ASP A 245LEU A 299SER A 22 | None MN A 400 ( 3.1A)NoneNone | 1.12A | 1ig3A-2chrA:undetectable1ig3B-2chrA:undetectable | 1ig3A-2chrA:22.281ig3B-2chrA:22.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2d3r | LECTIN ALPHA CHAIN (Cratyliaargentea) |
PF00139(Lectin_legB) | 4 | ASP A 207SER A 166SER A 168ASN A 167 | None | 1.18A | 1ig3A-2d3rA:2.71ig3B-2d3rA:2.8 | 1ig3A-2d3rA:22.791ig3B-2d3rA:22.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2dqi | LYSOZYME BINDING IGKAPPA CHAIN V23-J2REGION (Mus musculus) |
PF07686(V-set) | 4 | ASP L 82SER L 18SER L 74ASN L 76 | None | 1.25A | 1ig3A-2dqiL:undetectable1ig3B-2dqiL:undetectable | 1ig3A-2dqiL:15.591ig3B-2dqiL:15.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2f17 | THIAMINPYROPHOSPHOKINASE 1 (Mus musculus) |
PF04263(TPK_catalytic)PF04265(TPK_B1_binding) | 5 | TRP A 202LEU A 204SER A 216SER A 218ASN A 219 | None | 0.21A | 1ig3A-2f17A:42.01ig3B-2f17A:41.5 | 1ig3A-2f17A:100.001ig3B-2f17A:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ft3 | BIGLYCAN (Bos taurus) |
PF01462(LRRNT)PF13855(LRR_8) | 4 | GLN A 62LEU A 69SER A 110ASN A 112 | None | 1.12A | 1ig3A-2ft3A:undetectable1ig3B-2ft3A:undetectable | 1ig3A-2ft3A:21.131ig3B-2ft3A:21.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ik8 | GUANINENUCLEOTIDE-BINDINGPROTEIN G(I),ALPHA-1 SUBUNIT (Homo sapiens) |
PF00503(G-alpha) | 4 | GLN A 172ASP A 173LEU A 159SER A 151 | NoneNoneNoneGDP A 401 (-3.6A) | 0.95A | 1ig3A-2ik8A:undetectable1ig3B-2ik8A:2.8 | 1ig3A-2ik8A:20.721ig3B-2ik8A:20.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2lqj | MG2+ TRANSPORTPROTEIN (Mycobacteriumtuberculosis) |
no annotation | 4 | GLN A 169LEU A 207SER A 172ASN A 174 | None | 1.15A | 1ig3A-2lqjA:undetectable1ig3B-2lqjA:undetectable | 1ig3A-2lqjA:19.601ig3B-2lqjA:19.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2po4 | VIRION RNAPOLYMERASE (Escherichiavirus N4) |
no annotation | 4 | ASP A 389SER A 396SER A 280ASN A 285 | None | 1.23A | 1ig3A-2po4A:undetectable1ig3B-2po4A:undetectable | 1ig3A-2po4A:12.791ig3B-2po4A:12.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qt6 | LACCASE (Lentinustigrinus) |
PF00394(Cu-oxidase)PF07731(Cu-oxidase_2)PF07732(Cu-oxidase_3) | 4 | GLN A 51LEU A 493SER A 92ASN A 91 | None | 1.15A | 1ig3A-2qt6A:undetectable1ig3B-2qt6A:undetectable | 1ig3A-2qt6A:20.201ig3B-2qt6A:20.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qzp | ACYLAMINO-ACID-RELEASING ENZYME (Aeropyrumpernix) |
PF00326(Peptidase_S9) | 4 | GLN A 282SER A 375SER A 301ASN A 284 | None | 1.22A | 1ig3A-2qzpA:2.11ig3B-2qzpA:2.2 | 1ig3A-2qzpA:19.741ig3B-2qzpA:19.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2rcc | RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASESUBUNIT BETA (Bacillushalodurans) |
PF00268(Ribonuc_red_sm) | 4 | ASP A 104SER A 27SER A 15ASN A 16 | None | 1.19A | 1ig3A-2rccA:undetectable1ig3B-2rccA:undetectable | 1ig3A-2rccA:23.801ig3B-2rccA:23.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vk9 | ALPHA-TOXIN (Clostridiumnovyi) |
PF12918(TcdB_N)PF12919(TcdA_TcdB) | 4 | ASP A 268LEU A 526SER A 470ASN A 469 | None | 1.21A | 1ig3A-2vk9A:undetectable1ig3B-2vk9A:undetectable | 1ig3A-2vk9A:19.031ig3B-2vk9A:19.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wau | ERYTHROCYTE MEMBRANEPROTEIN 1 (PFEMP1) (Plasmodiumfalciparum) |
PF05424(Duffy_binding) | 4 | GLN A2575LEU A2605SER A2571ASN A2573 | None | 1.15A | 1ig3A-2wauA:undetectable1ig3B-2wauA:undetectable | 1ig3A-2wauA:16.201ig3B-2wauA:16.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wkn | FORMAMIDASE (Delftiaacidovorans) |
PF03069(FmdA_AmdA) | 4 | GLN A 19LEU A 158SER A 247SER A 73 | None | 1.16A | 1ig3A-2wknA:3.01ig3B-2wknA:2.8 | 1ig3A-2wknA:21.001ig3B-2wknA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2z4t | BETA-GALACTOSIDEALPHA-2,6-SIALYLTRANSFERASE (Photobacteriumsp. JT-ISH-224) |
PF11477(PM0188) | 4 | ASP A 232LEU A 171SER A 205ASN A 208 | LBT A2000 ( 2.9A)NoneNoneNone | 1.21A | 1ig3A-2z4tA:3.91ig3B-2z4tA:3.9 | 1ig3A-2z4tA:17.331ig3B-2z4tA:17.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2z7x | TOLL-LIKE RECEPTOR1, VARIABLELYMPHOCYTE RECEPTORB (Eptatretusburgeri;Homo sapiens) |
PF11921(DUF3439)PF13855(LRR_8) | 4 | GLN B 380LEU B 387SER B 431ASN B 433 | NAG A 831 ( 3.8A)NoneNAG A 831 (-3.6A)None | 1.10A | 1ig3A-2z7xB:undetectable1ig3B-2z7xB:undetectable | 1ig3A-2z7xB:20.081ig3B-2z7xB:20.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2z7x | TOLL-LIKE RECEPTOR1, VARIABLELYMPHOCYTE RECEPTORB (Eptatretusburgeri;Homo sapiens) |
PF11921(DUF3439)PF13855(LRR_8) | 4 | GLN B 380LEU B 387SER B 432ASN B 433 | NAG A 831 ( 3.8A)NoneNAG A 833 ( 3.9A)None | 1.01A | 1ig3A-2z7xB:undetectable1ig3B-2z7xB:undetectable | 1ig3A-2z7xB:20.081ig3B-2z7xB:20.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2znw | SCFV10 (Mus musculus;syntheticconstruct) |
PF07686(V-set) | 4 | ASP A 82SER A 18SER A 74ASN A 76 | None | 1.15A | 1ig3A-2znwA:undetectable1ig3B-2znwA:undetectable | 1ig3A-2znwA:21.231ig3B-2znwA:21.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3a8u | OMEGA-AMINOACID--PYRUVATEAMINOTRANSFERASE (Pseudomonasputida) |
PF00202(Aminotran_3) | 4 | GLN X 177ASP X 178LEU X 211SER X 161 | None | 1.24A | 1ig3A-3a8uX:1.51ig3B-3a8uX:undetectable | 1ig3A-3a8uX:18.601ig3B-3a8uX:18.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3c7k | GUANINENUCLEOTIDE-BINDINGPROTEIN G(O) SUBUNITALPHA (Mus musculus) |
PF00503(G-alpha) | 4 | GLN A 173ASP A 174LEU A 160SER A 152 | NoneNoneNoneGDP A 361 (-3.2A) | 0.92A | 1ig3A-3c7kA:undetectable1ig3B-3c7kA:2.3 | 1ig3A-3c7kA:21.701ig3B-3c7kA:21.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3dwb | ENDOTHELIN-CONVERTING ENZYME 1 (Homo sapiens) |
PF01431(Peptidase_M13)PF05649(Peptidase_M13_N) | 4 | GLN A 408ASP A 407LEU A 292SER A 403 | None | 1.17A | 1ig3A-3dwbA:undetectable1ig3B-3dwbA:undetectable | 1ig3A-3dwbA:17.651ig3B-3dwbA:17.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fgw | PUTATIVEPHOSPHOLIPASE B-LIKE2 (Mus musculus) |
PF04916(Phospholip_B) | 4 | ASP A 594TRP A 593SER A 64ASN A 93 | NoneNoneNAG A 1 (-2.9A)NAG A 1 (-2.1A) | 1.12A | 1ig3A-3fgwA:undetectable1ig3B-3fgwA:undetectable | 1ig3A-3fgwA:18.881ig3B-3fgwA:18.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h0g | DNA-DIRECTED RNAPOLYMERASE IISUBUNIT RPB3DNA-DIRECTED RNAPOLYMERASES I, II,AND III SUBUNITRPABC5 (Schizosaccharomycespombe) |
PF01000(RNA_pol_A_bac)PF01193(RNA_pol_L)PF01194(RNA_pol_N) | 4 | GLN J 41SER C 235SER C 16ASN C 15 | None | 1.25A | 1ig3A-3h0gJ:undetectable1ig3B-3h0gJ:undetectable | 1ig3A-3h0gJ:13.391ig3B-3h0gJ:13.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hn5 | PUTATIVE EXPORTEDPROTEIN BF0290 (Bacteroidesfragilis) |
PF12866(DUF3823) | 4 | GLN A 55LEU A 46SER A 92ASN A 94 | None | 1.09A | 1ig3A-3hn5A:undetectable1ig3B-3hn5A:undetectable | 1ig3A-3hn5A:22.261ig3B-3hn5A:22.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3htx | HEN1 (Arabidopsisthaliana) |
PF13847(Methyltransf_31) | 4 | GLN A 45LEU A 50SER A 34SER A 36 | G B 16 ( 4.3A)NoneNoneNone | 1.11A | 1ig3A-3htxA:2.51ig3B-3htxA:2.9 | 1ig3A-3htxA:15.661ig3B-3htxA:15.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hzu | THIOSULFATESULFURTRANSFERASESSEA (Mycobacteriumtuberculosis) |
PF00581(Rhodanese) | 4 | ASP A 217LEU A 20SER A 100ASN A 101 | None | 1.01A | 1ig3A-3hzuA:undetectable1ig3B-3hzuA:undetectable | 1ig3A-3hzuA:23.961ig3B-3hzuA:23.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ib3 | COCE/NOND FAMILYHYDROLASE (Staphylococcusaureus) |
PF02129(Peptidase_S15)PF08530(PepX_C) | 4 | GLN A 391ASP A 392SER A 516SER A 386 | None | 1.25A | 1ig3A-3ib3A:undetectable1ig3B-3ib3A:2.4 | 1ig3A-3ib3A:17.471ig3B-3ib3A:17.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ilr | HEPARIN LYASE I (Bacteroidesthetaiotaomicron) |
PF14099(Polysacc_lyase) | 4 | ASP A 254SER A 276SER A 244ASN A 243 | NoneNoneNoneSGN A 377 (-3.5A) | 1.23A | 1ig3A-3ilrA:undetectable1ig3B-3ilrA:undetectable | 1ig3A-3ilrA:20.261ig3B-3ilrA:20.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3jbl | NLR FAMILY CARDDOMAIN-CONTAININGPROTEIN 4 (Mus musculus) |
no annotation | 4 | GLN K 372LEU K 421SER K 375ASN K 374 | None | 1.21A | 1ig3A-3jblK:undetectable1ig3B-3jblK:undetectable | 1ig3A-3jblK:15.821ig3B-3jblK:15.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3kiz | PHOSPHORIBOSYLFORMYLGLYCINAMIDINECYCLO-LIGASE (Cytophagahutchinsonii) |
PF02769(AIRS_C) | 4 | ASP A 84LEU A 317SER A 289ASN A 337 | NoneNoneACT A 396 ( 4.6A)None | 1.01A | 1ig3A-3kizA:undetectable1ig3B-3kizA:undetectable | 1ig3A-3kizA:20.791ig3B-3kizA:20.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3l9y | SUPEROXIDE DISMUTASE[CU-ZN] (Bombyx mori) |
PF00080(Sod_Cu) | 4 | GLN A 100ASP A 101LEU A 117SER A 98 | None | 1.18A | 1ig3A-3l9yA:undetectable1ig3B-3l9yA:undetectable | 1ig3A-3l9yA:19.771ig3B-3l9yA:19.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lk7 | UDP-N-ACETYLMURAMOYLALANINE--D-GLUTAMATELIGASE (Streptococcusagalactiae) |
PF02875(Mur_ligase_C)PF08245(Mur_ligase_M) | 4 | GLN A 315LEU A 341SER A 422SER A 329 | None | 1.05A | 1ig3A-3lk7A:undetectable1ig3B-3lk7A:4.5 | 1ig3A-3lk7A:20.041ig3B-3lk7A:20.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3m9u | FARNESYL-DIPHOSPHATESYNTHASE (Lactobacillusbrevis) |
PF00348(polyprenyl_synt) | 4 | GLN A 34LEU A 122SER A 42ASN A 106 | NoneNoneGOL A 310 (-3.4A)None | 1.26A | 1ig3A-3m9uA:undetectable1ig3B-3m9uA:undetectable | 1ig3A-3m9uA:22.121ig3B-3m9uA:22.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n05 | NH(3)-DEPENDENTNAD(+) SYNTHETASE (Streptomycesavermitilis) |
PF00795(CN_hydrolase)PF02540(NAD_synthase) | 4 | GLN A 246ASP A 228LEU A 216SER A 248 | None | 1.26A | 1ig3A-3n05A:2.01ig3B-3n05A:2.4 | 1ig3A-3n05A:18.971ig3B-3n05A:18.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3oev | PROTEASOME COMPONENTY13 (Saccharomycescerevisiae) |
PF00227(Proteasome)PF10584(Proteasome_A_N) | 4 | ASP B 118SER B 154SER B 151ASN B 156 | None | 0.92A | 1ig3A-3oevB:undetectable1ig3B-3oevB:undetectable | 1ig3A-3oevB:22.151ig3B-3oevB:22.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3poy | NEUREXIN-1-ALPHA (Bos taurus) |
PF00008(EGF)PF02210(Laminin_G_2) | 4 | GLN A 675ASP A 673SER A 454ASN A 455 | None | 1.23A | 1ig3A-3poyA:undetectable1ig3B-3poyA:undetectable | 1ig3A-3poyA:13.881ig3B-3poyA:13.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pt1 | UPF0364 PROTEINYMR027W (Saccharomycescerevisiae) |
PF01937(DUF89) | 4 | ASP A 227LEU A 390SER A 416SER A 466 | None | 1.18A | 1ig3A-3pt1A:undetectable1ig3B-3pt1A:undetectable | 1ig3A-3pt1A:21.191ig3B-3pt1A:21.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qvo | NMRA FAMILY PROTEIN (Shigellaflexneri) |
PF13460(NAD_binding_10) | 4 | GLN A 82ASP A 78SER A 85ASN A 84 | None | 1.16A | 1ig3A-3qvoA:3.31ig3B-3qvoA:3.2 | 1ig3A-3qvoA:24.321ig3B-3qvoA:24.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3s4y | THIAMINPYROPHOSPHOKINASE 1 (Homo sapiens) |
PF04263(TPK_catalytic)PF04265(TPK_B1_binding) | 5 | TRP A 202LEU A 204SER A 216SER A 218ASN A 219 | None | 0.21A | 1ig3A-3s4yA:35.11ig3B-3s4yA:35.6 | 1ig3A-3s4yA:82.201ig3B-3s4yA:82.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3t6q | CD180 ANTIGEN (Mus musculus) |
PF13855(LRR_8) | 4 | GLN A 463LEU A 519SER A 460ASN A 490 | None | 1.16A | 1ig3A-3t6qA:undetectable1ig3B-3t6qA:undetectable | 1ig3A-3t6qA:16.781ig3B-3t6qA:16.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3txo | PROTEIN KINASE C ETATYPE (Homo sapiens) |
PF00069(Pkinase)PF00433(Pkinase_C) | 4 | ASP A 472LEU A 609SER A 465ASN A 623 | None | 1.17A | 1ig3A-3txoA:undetectable1ig3B-3txoA:undetectable | 1ig3A-3txoA:21.431ig3B-3txoA:21.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3uca | GERANYLTRANSTRANSFERASE (Clostridiumperfringens) |
PF00348(polyprenyl_synt) | 4 | ASP A 41LEU A 124SER A 46ASN A 108 | None | 1.12A | 1ig3A-3ucaA:undetectable1ig3B-3ucaA:undetectable | 1ig3A-3ucaA:23.191ig3B-3ucaA:23.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ups | IOJAP-LIKE PROTEIN (Zymomonasmobilis) |
PF02410(RsfS) | 4 | GLN A 60ASP A 30LEU A 93SER A 54 | None | 1.09A | 1ig3A-3upsA:undetectable1ig3B-3upsA:undetectable | 1ig3A-3upsA:20.771ig3B-3upsA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3vv3 | DESEASIN MCP-01 (Pseudoalteromonassp. SM9913) |
PF00082(Peptidase_S8) | 4 | ASP A 58LEU A 11SER A 255SER A 109 | None | 1.20A | 1ig3A-3vv3A:2.41ig3B-3vv3A:2.3 | 1ig3A-3vv3A:20.301ig3B-3vv3A:20.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ww0 | PROTEIN HIKESHI (Homo sapiens) |
PF05603(DUF775) | 4 | ASP B 136LEU B 193SER B 133ASN B 129 | None | 1.15A | 1ig3A-3ww0B:undetectable1ig3B-3ww0B:2.5 | 1ig3A-3ww0B:18.701ig3B-3ww0B:18.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4aw7 | GH86ABETA-PORPHYRANASE (Bacteroidesplebeius) |
no annotation | 4 | ASP A 259LEU A 311SER A 254SER A 252 | None | 1.00A | 1ig3A-4aw7A:2.31ig3B-4aw7A:3.7 | 1ig3A-4aw7A:20.781ig3B-4aw7A:20.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bx9 | VACUOLAR PROTEINSORTING-ASSOCIATEDPROTEIN 33A (Homo sapiens) |
PF00995(Sec1) | 4 | GLN A 378TRP A 473SER A 486SER A 490 | None | 1.23A | 1ig3A-4bx9A:2.31ig3B-4bx9A:2.7 | 1ig3A-4bx9A:18.001ig3B-4bx9A:18.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dy0 | GLIA-DERIVED NEXIN (Homo sapiens) |
PF00079(Serpin) | 4 | LEU A 235SER A 233SER A 231ASN A 365 | None | 1.14A | 1ig3A-4dy0A:undetectable1ig3B-4dy0A:undetectable | 1ig3A-4dy0A:21.941ig3B-4dy0A:21.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4epa | PESTICIN RECEPTOR (Yersinia pestis) |
PF00593(TonB_dep_Rec)PF07715(Plug) | 4 | ASP A 363LEU A 111SER A 15SER A 18 | None | 1.24A | 1ig3A-4epaA:undetectable1ig3B-4epaA:undetectable | 1ig3A-4epaA:20.091ig3B-4epaA:20.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fc9 | UNCHARACTERIZEDPROTEIN (Xanthomonaseuvesicatoria) |
no annotation | 4 | ASP B 603LEU B 533SER B 514ASN B 506 | None | 1.22A | 1ig3A-4fc9B:undetectable1ig3B-4fc9B:undetectable | 1ig3A-4fc9B:26.281ig3B-4fc9B:26.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fle | ESTERASE (Yersiniaenterocolitica) |
PF05728(UPF0227) | 4 | GLN A 40LEU A 118SER A 13ASN A 12 | None | 0.96A | 1ig3A-4fleA:undetectable1ig3B-4fleA:undetectable | 1ig3A-4fleA:21.291ig3B-4fleA:21.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gz2 | TYROSYL-DNAPHOSPHODIESTERASE 2 (Mus musculus) |
PF03372(Exo_endo_phos) | 4 | ASP A 156LEU A 337SER A 224ASN A 228 | None | 1.23A | 1ig3A-4gz2A:undetectable1ig3B-4gz2A:undetectable | 1ig3A-4gz2A:23.591ig3B-4gz2A:23.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4h5s | CYTOTOXIC ANDREGULATORY T-CELLMOLECULE (Homo sapiens) |
PF07686(V-set) | 4 | GLN A 74ASP A 75LEU A 49SER A 37 | None | 1.02A | 1ig3A-4h5sA:undetectable1ig3B-4h5sA:undetectable | 1ig3A-4h5sA:17.441ig3B-4h5sA:17.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hhr | ALPHA-DIOXYGENASE (Arabidopsisthaliana) |
PF03098(An_peroxidase) | 4 | ASP A 99LEU A 71SER A 377SER A 110 | None | 1.16A | 1ig3A-4hhrA:undetectable1ig3B-4hhrA:undetectable | 1ig3A-4hhrA:19.661ig3B-4hhrA:19.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4m1g | MURINE IGG2A A27D7HEAVY CHAIN FABDOMAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | ASP H 89SER H 84SER H 17ASN H 83 | None | 1.23A | 1ig3A-4m1gH:undetectable1ig3B-4m1gH:undetectable | 1ig3A-4m1gH:21.431ig3B-4m1gH:21.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mn7 | PUTATIVEUNCHARACTERIZEDPROTEIN TA0848 (Thermoplasmaacidophilum) |
PF13185(GAF_2) | 4 | GLN A 89ASP A 74LEU A 59SER A 110 | None | 1.23A | 1ig3A-4mn7A:undetectable1ig3B-4mn7A:undetectable | 1ig3A-4mn7A:20.311ig3B-4mn7A:20.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qdg | PUTATIVE ADHESIN (Bacteroidesthetaiotaomicron) |
PF08842(Mfa2) | 4 | ASP A 204LEU A 284SER A 250ASN A 179 | NoneNoneNone MG A 402 (-2.8A) | 1.15A | 1ig3A-4qdgA:undetectable1ig3B-4qdgA:undetectable | 1ig3A-4qdgA:22.291ig3B-4qdgA:22.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rvw | ZNUD (Neisseriameningitidis) |
PF00593(TonB_dep_Rec)PF07715(Plug) | 4 | ASP A 95LEU A 84SER A 124ASN A 127 | None | 0.86A | 1ig3A-4rvwA:undetectable1ig3B-4rvwA:undetectable | 1ig3A-4rvwA:17.661ig3B-4rvwA:17.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wyk | NTF2-RELATED EXPORTPROTEIN 1NUCLEAR RNA EXPORTFACTOR 1 (Homo sapiens) |
PF02136(NTF2) | 4 | GLN B 136ASP B 137LEU A 370SER B 98 | None | 1.18A | 1ig3A-4wykB:undetectable1ig3B-4wykB:undetectable | 1ig3A-4wykB:18.251ig3B-4wykB:18.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xgc | ORIGIN RECOGNITIONCOMPLEX SUBUNIT 4 (Drosophilamelanogaster) |
PF13191(AAA_16)PF14629(ORC4_C) | 4 | GLN D 169ASP D 166LEU D 129SER D 51 | None | 1.06A | 1ig3A-4xgcD:undetectable1ig3B-4xgcD:undetectable | 1ig3A-4xgcD:20.001ig3B-4xgcD:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xmm | NUCLEOPORIN NUP120 (Saccharomycescerevisiae) |
no annotation | 4 | ASP E 258LEU E 293SER E 263ASN E 318 | None | 1.24A | 1ig3A-4xmmE:undetectable1ig3B-4xmmE:undetectable | 1ig3A-4xmmE:15.041ig3B-4xmmE:15.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yis | MEGANUCLEASE I-CPAMI (Cryphonectriaparasitica) |
PF00961(LAGLIDADG_1) | 4 | GLN A 74LEU A 11SER A 15SER A 20 | None | 1.21A | 1ig3A-4yisA:undetectable1ig3B-4yisA:undetectable | 1ig3A-4yisA:19.741ig3B-4yisA:19.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5b0n | E3 UBIQUITIN-PROTEINLIGASE IPAH9.8 (Shigellaflexneri) |
PF12468(TTSSLRR) | 4 | ASP A 64SER A 104SER A 106ASN A 107 | None | 1.17A | 1ig3A-5b0nA:undetectable1ig3B-5b0nA:undetectable | 1ig3A-5b0nA:21.321ig3B-5b0nA:21.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5djw | ALPHA-GLUCOSIDASE II (Bacteroidesthetaiotaomicron) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 4 | ASP A 617LEU A 176SER A 591ASN A 590 | None | 1.05A | 1ig3A-5djwA:undetectable1ig3B-5djwA:undetectable | 1ig3A-5djwA:16.501ig3B-5djwA:16.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ei0 | SERPIN A12 (Homo sapiens) |
PF00079(Serpin) | 4 | GLN A 288ASP A 54LEU A 393SER A 293 | None | 1.19A | 1ig3A-5ei0A:undetectable1ig3B-5ei0A:undetectable | 1ig3A-5ei0A:23.501ig3B-5ei0A:23.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7u | CYCLOALTERNAN-FORMING ENZYME (Listeriamonocytogenes) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16338(DUF4968)PF16990(CBM_35) | 4 | GLN A 371ASP A 370SER A 367ASN A 377 | NoneNoneNone MG A1102 (-2.6A) | 1.24A | 1ig3A-5f7uA:2.71ig3B-5f7uA:3.1 | 1ig3A-5f7uA:12.261ig3B-5f7uA:12.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fq6 | SUSC/RAGA FAMILYTONB-LINKED OUTERMEMBRANE PROTEIN (Bacteroidesthetaiotaomicron) |
PF00593(TonB_dep_Rec)PF07715(Plug) | 4 | GLN B 459ASP B 460LEU B 101ASN B 483 | KR0 B1985 (-3.6A)NoneNoneNone | 1.26A | 1ig3A-5fq6B:undetectable1ig3B-5fq6B:undetectable | 1ig3A-5fq6B:14.811ig3B-5fq6B:14.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fur | TRANSCRIPTIONINITIATION FACTORTFIID SUBUNIT 2 (Homo sapiens) |
no annotation | 4 | GLN I 352LEU I 284SER I 323ASN I 328 | None | 1.25A | 1ig3A-5furI:undetectable1ig3B-5furI:undetectable | 1ig3A-5furI:12.061ig3B-5furI:12.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fur | TRANSCRIPTIONINITIATION FACTORTFIID SUBUNIT 2 (Homo sapiens) |
no annotation | 4 | GLN I 662ASP I 658LEU I 399SER I 665 | None | 1.26A | 1ig3A-5furI:undetectable1ig3B-5furI:undetectable | 1ig3A-5furI:12.061ig3B-5furI:12.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ktk | POLYKETIDE SYNTHASEPKSJ (Bacillussubtilis) |
PF08659(KR) | 4 | ASP A 385SER A 373SER A 391ASN A 390 | NoneNoneNoneNDP A 601 ( 4.5A) | 1.17A | 1ig3A-5ktkA:undetectable1ig3B-5ktkA:2.5 | 1ig3A-5ktkA:17.621ig3B-5ktkA:17.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kzt | PEPTIDE/NICKELTRANSPORT SYSTEMSUBSTRATE-BINDINGPROTEIN (Listeriamonocytogenes) |
PF00496(SBP_bac_5) | 4 | GLN A 417ASP A 418LEU A 524SER A 412 | None | 1.19A | 1ig3A-5kztA:undetectable1ig3B-5kztA:undetectable | 1ig3A-5kztA:19.841ig3B-5kztA:19.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lfn | CHONDROADHERIN (Homo sapiens) |
PF00560(LRR_1)PF01462(LRRNT)PF13855(LRR_8) | 4 | GLN A 59LEU A 66SER A 107ASN A 109 | None | 1.19A | 1ig3A-5lfnA:undetectable1ig3B-5lfnA:undetectable | 1ig3A-5lfnA:21.041ig3B-5lfnA:21.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lvc | VP1 (Aichivirus A) |
no annotation | 4 | ASP a 211LEU a 202SER a 110ASN a 111 | None | 0.93A | 1ig3A-5lvca:3.21ig3B-5lvca:undetectable | 1ig3A-5lvca:23.371ig3B-5lvca:23.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5mqs | BETA-L-ARABINOBIOSIDASE (Bacteroidesthetaiotaomicron) |
PF13088(BNR_2) | 4 | TRP A 400LEU A 335SER A 402ASN A 54 | None | 1.15A | 1ig3A-5mqsA:undetectable1ig3B-5mqsA:undetectable | 1ig3A-5mqsA:13.721ig3B-5mqsA:13.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5oup | PERFORIN-LIKEPROTEIN 1 (Toxoplasmagondii) |
no annotation | 4 | ASP A 474SER A 565SER A 563ASN A 562 | None | 1.25A | 1ig3A-5oupA:undetectable1ig3B-5oupA:undetectable | 1ig3A-5oupA:14.181ig3B-5oupA:14.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tj3 | ALKALINE PHOSPHATASEPAFA (Elizabethkingiameningoseptica) |
PF01663(Phosphodiest) | 4 | LEU A 45SER A 66SER A 510ASN A 68 | None | 1.15A | 1ig3A-5tj3A:2.11ig3B-5tj3A:2.0 | 1ig3A-5tj3A:19.021ig3B-5tj3A:19.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uj7 | ORIGIN RECOGNITIONCOMPLEX SUBUNIT 4 (Homo sapiens) |
PF13191(AAA_16)PF14629(ORC4_C) | 4 | GLN C 181ASP C 178LEU C 140SER C 62 | None | 1.23A | 1ig3A-5uj7C:undetectable1ig3B-5uj7C:undetectable | 1ig3A-5uj7C:21.251ig3B-5uj7C:21.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ukg | K-GECO (Entacmaeaquadricolor) |
no annotation | 4 | GLN A 273LEU A 63SER A 265ASN A 32 | NoneNoneNoneNRQ A 186 ( 3.6A) | 1.25A | 1ig3A-5ukgA:undetectable1ig3B-5ukgA:undetectable | 1ig3A-5ukgA:20.441ig3B-5ukgA:20.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vjo | HYHEL10 LIGHT CHAINFAB FRAGMENT (Mus musculus) |
no annotation | 4 | ASP B 82SER B 18SER B 74ASN B 76 | None | 1.26A | 1ig3A-5vjoB:undetectable1ig3B-5vjoB:undetectable | 1ig3A-5vjoB:14.341ig3B-5vjoB:14.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vm1 | XYLULOKINASE (Brucella ovis) |
PF00370(FGGY_N)PF02782(FGGY_C) | 4 | GLN A 312ASP A 315LEU A 417SER A 398 | None | 1.00A | 1ig3A-5vm1A:undetectable1ig3B-5vm1A:undetectable | 1ig3A-5vm1A:19.231ig3B-5vm1A:19.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vqi | IMPORTIN SUBUNITALPHA (Neurosporacrassa) |
no annotation | 4 | GLN B 414LEU B 427SER B 402SER B 406 | None | 1.07A | 1ig3A-5vqiB:undetectable1ig3B-5vqiB:undetectable | 1ig3A-5vqiB:21.661ig3B-5vqiB:21.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wfb | AP-4 COMPLEXACCESSORY SUBUNITTEPSIN (Homo sapiens) |
PF01417(ENTH) | 4 | GLN A 51LEU A 79SER A 43SER A 46 | None | 1.11A | 1ig3A-5wfbA:undetectable1ig3B-5wfbA:undetectable | 1ig3A-5wfbA:19.921ig3B-5wfbA:19.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xyj | ACETYL-COAACETYLTRANSFERASE (Saccharomycescerevisiae) |
no annotation | 4 | GLN B 19LEU B 30SER B 120ASN B 123 | None | 1.15A | 1ig3A-5xyjB:undetectable1ig3B-5xyjB:undetectable | 1ig3A-5xyjB:20.421ig3B-5xyjB:20.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5z9s | GLYCOSYL HYDROLASEFAMILY 3 PROTEIN (Bifidobacteriumlongum) |
no annotation | 4 | GLN A 416ASP A 414LEU A 469SER A 426 | None | 1.21A | 1ig3A-5z9sA:undetectable1ig3B-5z9sA:undetectable | 1ig3A-5z9sA:15.971ig3B-5z9sA:15.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6az1 | RIBOSOMAL PROTEIN S7 (Leishmaniadonovani) |
no annotation | 4 | ASP H 180SER H 170SER H 173ASN H 172 | None | 1.21A | 1ig3A-6az1H:undetectable1ig3B-6az1H:undetectable | 1ig3A-6az1H:14.891ig3B-6az1H:14.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6eoj | PROTEIN CFT1 (Saccharomycescerevisiae) |
no annotation | 4 | GLN A 990LEU A 969SER A1013ASN A1012 | None | 0.90A | 1ig3A-6eojA:undetectable1ig3B-6eojA:undetectable | 1ig3A-6eojA:11.841ig3B-6eojA:11.84 |